Accuray Incorporated Revenue Growth Rates (ARAY), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Accuray Incorporated  (NASDAQ: ARAY)
 

ARAY's Revenue Growth by Quarter and Year

Accuray Incorporated's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ARAY/growth
https://api.csimarket.com/api/v1/companies/ARAY/fundamentals
https://api.csimarket.com/api/v1/companies/ARAY/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
ARAY Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter June -
3rd Quarter March -
2nd Quarter December -
1st Quarter September 86.52
FY 86.52

ARAYs Annual Revenue
Accuray Incorporated's Revenue in the fiscal year 2026 $ 401.95 millions
Accuray Incorporated's Revenue in the fiscal year 2025 $ 457.97 millions
Accuray Incorporated's Revenue in the fiscal year 2024 $ 445.92 millions
Accuray Incorporated's Revenue in the fiscal year 2023 $ 446.96 millions
Accuray Incorporated's Revenue in the fiscal year 2022 $ 429.91 millions




ARAY Revenue first quarter 2026 Y/Y Growth Comment
Accuray Incorporated reported decrease in Revenue in the first quarter 2026 by -7.51% to $ 86.52 millions, from the same quarter in 2025.
The decrease in the first quarter 2026 Accuray Incorporated's Revenue compares unfavorably to the Company's average Revenue growth of 2.52%.

Looking into first quarter 2026 results within Medical Equipment & Supplies industry 138 other companies have achieved higher Revenue growth. While Accuray Incorporated' s Revenue decline of -7.51% ranks overall at the positon no. 2606 in the first quarter 2026.


ARAY Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter June -
3rd Quarter March -
2nd Quarter December -
1st Quarter September -7.51 %
FY   -

Financial Statements
Accuray Incorporated's first quarter 2026 Revenue $ 86.52 millions ARAY's Income Statement
Accuray Incorporated's first quarter 2025 Revenue $ 93.55 millions Quarterly ARAY's Income Statement


ARAY Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter June -
3rd Quarter March -
2nd Quarter December -
1st Quarter September -14.27 %
FY (Year on Year)   -


Back to ARAY Growth rate Comparisons >> Back to ARAY Growth rate Comparisons >>


Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #139
Healthcare Sector #374
Overall #2606

Revenue Y/Y Growth Statistics
High Average Low
21.07 % 2.52 % -12.48 %
(Sep 30 2014)   (Jun 30 2026)
Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #139
Healthcare Sector #374
Overall #2606
Revenue Y/Y Growth Statistics
High Average Low
21.07 % 2.52 % -12.48 %
(Sep 30 2014)   (Jun 30 2026)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Accuray Incorporated's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
42.5 % 2.61 % -26.9 %
(Dec 31 2010)  


ARAY's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2026 Accuray Incorporated disclosed drop in Revenue from the fourth quarter by -14.27% to $ 86.52 millions, from $ 100.92 millions achived in the previous reporting period.

But that's not important problem, as Accuray Incorporated's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 90 other companies have achieved higher Revenue quarter on quarter growth. While Accuray Incorporated's Revenue growth quarter on quarter, overall rank is 2293.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #91
Healthcare Sector #289
Overall #2293
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #91
Healthcare Sector #289
Overall #2293
Revenue Q/Q Growth Statistics
High Average Low
42.5 % 2.61 % -26.9 %
(Dec 31 2010)  


ARAY's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2026 Accuray Incorporated disclosed drop in Revenue from the fourth quarter by -14.27% to $ 86.52 millions, from $ 100.92 millions achived in the previous reporting period.

But that's not important problem, as Accuray Incorporated's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 90 other companies have achieved higher Revenue quarter on quarter growth. While Accuray Incorporated's Revenue growth quarter on quarter, overall rank is 2293.


Accuray Incorporated's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 400.83
Y / Y Revenue Growth (TTM) -12.48 %
Year on Year Revenue Growth Overall Ranking # 2213
Seqeuential Revenue Change (TTM) -6.32 %
Seq. Revenue Growth (TTM) Overall Ranking # 2606


Cumulative Revenue growth Comment
Accuray Incorporated's cumulative 12 months Revenue continue to fall, but on the faster rate at -12.48% year on year, at Jun 30 2026 compare to the -7.84% decrease at Mar 31 2026. If the Accuray Incorporated's fiscal year would end at Jun 30 2026, annual Revenue would be $401 millions.

In the Healthcare sector 320 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2123 to 2213.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 139
Healthcare Sector # 321
Overall # 2213

Revenue TTM Y/Y Growth Statistics
High Average Low
21.07 %
 2.52 %
-12.48 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 139
Sector # 374
S&P 500 # 2606
Cumulative Revenue growth Comment
Accuray Incorporated's cumulative 12 months Revenue continue to fall, but on the faster rate at -12.48% year on year, at Jun 30 2026 compare to the -7.84% decrease at Mar 31 2026. If the Accuray Incorporated's fiscal year would end at Jun 30 2026, annual Revenue would be $401 millions.

In the Healthcare sector 320 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2123 to 2213.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 139
Healthcare Sector # 321
Overall # 2213

Revenue TTM Y/Y Growth Statistics
High Average Low
21.07 %
2.52 %
-12.48 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 139
Sector # 374
S&P 500 # 2606




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ARAY's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Viatris Inc -0.28%$ -0.277 millions
Zoetis Inc -0.38%$ -0.375 millions
Pfizer Inc-0.43%$ -0.426 millions
Standard Biotools Inc -0.51%$ -0.508 millions
Lucid Diagnostics Inc -0.66%$ -0.661 millions
Globus Medical Inc -0.69%$ -0.693 millions
Conmed Corporation-0.70%$ -0.701 millions
Surgery Partners Inc -0.75%$ -0.755 millions
Myriad Genetics Inc -1.03%$ -1.025 millions
Lensar Inc -1.29%$ -1.292 millions
Fortrea Holdings Inc -1.40%$ -1.397 millions
Immunocore Holdings Plc-1.42%$ -1.419 millions
Pacira Biosciences inc -1.59%$ -1.595 millions
Organon and Co -1.75%$ -1.748 millions
Teva Pharmaceutical Industries Limited-1.90%$ -1.897 millions
Skinhealth Systems Inc -2.07%$ -2.071 millions
Charles River Laboratories International inc -2.20%$ -2.201 millions
Inogen Inc -2.40%$ -2.399 millions
Novavax inc -3.05%$ -3.048 millions
Seer Inc -3.14%$ -3.139 millions
Teladoc Health Inc -3.41%$ -3.406 millions
Scientific Industries Inc -3.50%$ -3.504 millions
Cg Oncology Inc -3.72%$ -3.721 millions
Treace Medical Concepts Inc -3.91%$ -3.905 millions
Sarepta Therapeutics Inc -4.51%$ -4.509 millions
Pacific Health Care Organization Inc-4.69%$ -4.689 millions
Tela Bio Inc -5.06%$ -5.058 millions
Perrigo Company Plc-5.22%$ -5.225 millions
Heron Therapeutics Inc -5.49%$ -5.493 millions
Milestone Scientific Inc -5.95%$ -5.948 millions


About Accuray Incorporated Revenue Growth Rates (ARAY), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Accuray Inc (CIK 1138723).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-26-035560
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Accuray Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.